5 Oct 2026, 16:31
Other—
BIOBIOME AUSTRALIA LIMITED
Announcement history available from 1 August 2025
Fromto
25 Sept 2026, 16:51
Securities Administration—
25 Sept 2026, 16:39
Securities Administration—
23 Sept 2026, 09:18
Meetings & Governance—
22 Sept 2026, 10:01
Company Administration—
22 Sept 2026, 10:00
Financial Results—
15 Sept 2026, 09:03
Presentations—
9 Sept 2026, 08:34
Company UpdateMS
27 Aug 2026, 08:59
Company UpdateMS
26 Aug 2026, 08:55
Financial ResultsMS
29 July 2026, 08:40
Quarterly ReportsMS
27 July 2026, 09:34
PresentationsMS
27 July 2026, 08:45
Presentations—
1 July 2026, 08:35
OtherMS
26 June 2026, 08:43
Director Interests—
12 June 2026, 17:41
Director Interests—
12 June 2026, 17:34
Substantial Holders—
11 June 2026, 08:53
Director Interests—
4 June 2026, 08:37
Director Interests—
3 June 2026, 08:43
Company UpdateMS
3 June 2026, 08:38
Presentations—
27 May 2026, 09:27
Presentations—
27 May 2026, 08:43
Company UpdateMS
12 May 2026, 08:37
Company UpdateMS
30 Apr 2026, 09:23
Director Interests—
29 Apr 2026, 09:29
Director Interests—
28 Apr 2026, 16:45
Quarterly Reports—
28 Apr 2026, 09:14
Quarterly ReportsMS
27 Apr 2026, 09:02
Company UpdateMS
10 Apr 2026, 17:11
Other—
1 Apr 2026, 12:00
Securities Administration—
30 Mar 2026, 17:53
Securities Administration—
30 Mar 2026, 17:46
Securities Administration—
20 Mar 2026, 10:01
Securities Administration—
20 Mar 2026, 09:57
Securities Administration—
20 Mar 2026, 09:52
Securities Administration—
19 Mar 2026, 09:39
Securities Administration—
17 Mar 2026, 18:02
Securities Administration—
17 Mar 2026, 17:57
Securities Administration—
13 Mar 2026, 08:26
Director Interests—
12 Mar 2026, 17:10
Securities Administration—
12 Mar 2026, 17:06
Securities Administration—
10 Mar 2026, 08:25
Securities Administration—
25 Feb 2026, 08:26
Financial Results—
23 Feb 2026, 08:44
Financial ResultsMS
23 Feb 2026, 08:22
Financial ResultsMS
18 Feb 2026, 08:14
Presentations—
3 Feb 2026, 08:17
Company UpdateMS
2 Feb 2026, 08:20
Company UpdateMS
27 Jan 2026, 08:46
Quarterly ReportsMS
| Date / Time | Heading | Type | MS | Report Codes | |
|---|---|---|---|---|---|
| 5 Oct 2026, 16:31 | Change of Auditor | Other | — | 12018 | |
| 25 Sept 2026, 16:51 | Secondary Trading Notice | Securities Administration | — | 06018 | |
| 25 Sept 2026, 16:39 | Application for quotation of securities - BIO | Securities Administration | — | 06020 | |
| 23 Sept 2026, 09:18 | Date of AGM and Closing Date for Director Nominations | Meetings & Governance | — | 08006 | |
| 22 Sept 2026, 10:01 | Appendix 4G & Corporate Governance Statement | Company Administration | — | 03024, 03025 | |
| 22 Sept 2026, 10:00 | Annual Report | Financial Results | — | 03001, 03002, 03011, 03012, 03013, 03020 | |
| 15 Sept 2026, 09:03 | Biome Investor Presentation | Presentations | — | 03026 | |
| 9 Sept 2026, 08:34 | New Activated Probiotics launches for H1 FY27 | Company Update | MS | 11001 | |
| 27 Aug 2026, 08:59 | Biome to Launch in China | Company Update | MS | 11001 | |
| 26 Aug 2026, 08:55 | Preliminary Final Report | Financial Results | MS | 03003 | |
| 29 July 2026, 08:40 | Quarterly Activities & Cashflow Report | Quarterly Reports | MS | 19004, 19009 | |
| 27 July 2026, 09:34 | International Markets Presentation | Presentations | MS | 03026 | |
| 27 July 2026, 08:45 | Investor Webinar | Presentations | — | 12008, 14014 | |
| 1 July 2026, 08:35 | FY26 Trading Update | Other | MS | 03028 | |
| 26 June 2026, 08:43 | Change of Director's Interest Notice | Director Interests | — | 02009 | |
| 12 June 2026, 17:41 | Change of Director's Interest Notice | Director Interests | — | 02009 | |
| 12 June 2026, 17:34 | Ceasing to be a substantial holder | Substantial Holders | — | 02003 | |
| 11 June 2026, 08:53 | Change of Director's Interest Notice | Director Interests | — | 02009 | |
| 4 June 2026, 08:37 | Change of Director's Interest Notice | Director Interests | — | 02009 | |
| 3 June 2026, 08:43 | Biome Signs Australian Manufacturing Agreement | Company Update | MS | 11001 | |
| 3 June 2026, 08:38 | Biome Investor Presentation June 2026 | Presentations | — | 03026 | |
| 27 May 2026, 09:27 | Investor Webinar | Presentations | — | 14014 | |
| 27 May 2026, 08:43 | BMB18 clinical trial expands to dual site | Company Update | MS | 11001 | |
| 12 May 2026, 08:37 | Probiotical Exclusive Supply Agreement Extended | Company Update | MS | 11001 | |
| 30 Apr 2026, 09:23 | Change of Director's Interest Notice | Director Interests | — | 02009 | |
| 29 Apr 2026, 09:29 | Change of Director's Interest Notice | Director Interests | — | 02009 | |
| 28 Apr 2026, 16:45 | Revised Appendix 4C Quarterly Cash Flow Report | Quarterly Reports | — | 04003, 05003 | |
| 28 Apr 2026, 09:14 | Quarterly Activities & Cashflow Report | Quarterly Reports | MS | 04003, 05003 | |
| 27 Apr 2026, 09:02 | Patent Application Filed for Probiotic Strain BMB18 | Company Update | MS | 11001 | |
| 10 Apr 2026, 17:11 | Change of Auditor | Other | — | 12018 | |
| 1 Apr 2026, 12:00 | Notification of cessation of securities - BIO | Securities Administration | — | 06027 | |
| 30 Mar 2026, 17:53 | Secondary Trading Notice | Securities Administration | — | 06018 | |
| 30 Mar 2026, 17:46 | Application for quotation of securities - BIO | Securities Administration | — | 06020 | |
| 20 Mar 2026, 10:01 | Secondary Trading Notice | Securities Administration | — | 06018 | |
| 20 Mar 2026, 09:57 | Application for quotation of securities - BIO | Securities Administration | — | 06020 | |
| 20 Mar 2026, 09:52 | Application for quotation of securities - BIO | Securities Administration | — | 06020 | |
| 19 Mar 2026, 09:39 | Proposed issue of securities - BIO | Securities Administration | — | 06013 | |
| 17 Mar 2026, 18:02 | Secondary Trading Notice | Securities Administration | — | 06018 | |
| 17 Mar 2026, 17:57 | Application for quotation of securities - BIO | Securities Administration | — | 06020 | |
| 13 Mar 2026, 08:26 | Change of Director's Interest Notice | Director Interests | — | 02009 | |
| 12 Mar 2026, 17:10 | Secondary Trading Notice | Securities Administration | — | 06018 | |
| 12 Mar 2026, 17:06 | Application for quotation of securities - BIO | Securities Administration | — | 06020 | |
| 10 Mar 2026, 08:25 | Expiry of Unlisted Options | Securities Administration | — | 06009 | |
| 25 Feb 2026, 08:26 | H1 FY26 Results & Company Presentation | Financial Results | — | 03004, 03026 | |
| 23 Feb 2026, 08:44 | Biome First Half FY26 Results and Highlights | Financial Results | MS | 03004 | |
| 23 Feb 2026, 08:22 | Appendix 4D & Half Yearly Report | Financial Results | MS | 03004, 03009, 03010, 03015, 03019 | |
| 18 Feb 2026, 08:14 | Biome Half Year Results and Webinar | Presentations | — | 03027, 14014 | |
| 3 Feb 2026, 08:17 | Ethics Approval Granted for BMB18 Human Clinical Trial | Company Update | MS | 11001 | |
| 2 Feb 2026, 08:20 | Biome secures distribution with Fullscript Canada | Company Update | MS | 11001 | |
| 27 Jan 2026, 08:46 | Quarterly Activities & Cashflow Report | Quarterly Reports | MS | 19002, 19007 |
1–50 of 71
1 / 2